BCRX
BioCryst Pharmaceuticals Inc
8.00$
-1.9%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +15.7% | +5.1% | -67.2% | +182.7% | -55.6% | +2.2% | +214.2% | -88.4% | +87.7% | +115.7% | -75.4% | +22.6% | +2,138.0% | -87.9% | -40.5% | +112.5% | -34.2% | +374.6% | +162.1% | -17.9% | +15.0% | +5.9% | +31.3% | +15.7% | +4.9% | -13.5% | +19.9% | +5.2% | +7.7% | -0.7% | +17.9% | +7.1% | +12.3% | +10.6% | +12.2% | -2.4% | +155.1% | -61.5% | +39.5% | – | |
| – | +1,614.7% | -88.0% | -92.5% | +5,613.6% | -89.7% | +8.5% | +73.6% | -92.6% | +288.9% | +2,022.9% | -98.3% | -30.8% | +14,183.3% | -97.3% | +39,752.2% | -94.5% | -94.7% | +7,212.3% | -94.2% | +79.3% | -31.9% | -43.2% | +3.8% | +1,362.8% | -30.9% | -62.4% | +1.3% | +19.6% | +44.1% | -22.7% | +34.3% | +90.0% | +89.9% | -25.5% | -38.7% | -9.9% | +293.2% | +6,990.9% | -99.5% | – | |
| – | -14.3% | +40.0% | -66.3% | +143.8% | -49.9% | +2.0% | +219.4% | -88.3% | +85.2% | +65.5% | -67.7% | +23.6% | +2,014.6% | -87.2% | -39.6% | +59.4% | -14.0% | +233.8% | +277.7% | -18.6% | +15.8% | +6.3% | +31.4% | +10.6% | +6.7% | -12.0% | +20.2% | +5.0% | +7.2% | -0.3% | +17.6% | +5.8% | +10.1% | +12.4% | +13.9% | -2.3% | +152.8% | -237.8% | – | – | |
| – | -13.8% | +37.9% | -6.0% | +11.1% | -3.3% | +9.0% | +13.9% | +4.7% | +6.5% | +17.3% | +0.7% | -9.3% | +6.6% | +11.6% | -7.9% | +10.0% | +16.9% | +20.0% | +24.6% | -5.5% | +27.1% | +2.9% | -5.2% | -14.9% | +38.8% | -33.9% | +5.9% | -8.5% | +49.4% | -33.6% | -19.1% | +9.2% | +20.4% | -24.6% | +16.4% | +2.0% | -6.9% | +46.4% | -13.8% | – | |
| – | -7.1% | +19.4% | -7.3% | +18.0% | +40.5% | +62.0% | +24.7% | -16.5% | -43.3% | +38.9% | +38.8% | +35.5% | -10.6% | +51.3% | -12.5% | +23.9% | +173.0% | -55.9% | +18.4% | +36.6% | +2.6% | -11.9% | +12.0% | +8.8% | +26.8% | -6.4% | +8.9% | +6.2% | -1.3% | +18.8% | +3.1% | +6.3% | +23.6% | +2.5% | +6.0% | -5.0% | +15.4% | -1.3% | -32.3% | – | |
| – | -12.7% | +34.7% | -6.2% | +12.1% | +3.7% | +20.5% | +17.1% | -1.9% | -6.7% | +20.8% | +7.7% | +1.4% | +1.1% | +22.7% | -9.5% | +14.6% | +18.8% | +14.5% | +22.8% | +7.3% | +16.4% | +0.7% | +0.4% | -10.3% | +37.6% | -22.0% | +6.2% | -4.6% | +37.8% | -21.2% | -6.7% | +7.4% | +22.4% | -7.8% | +9.2% | -2.7% | +7.4% | +13.3% | -25.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -12.2% | -158.6% | – | +40.3% | -0.7% | +779.9% | -369.4% | – | – | |
| – | +45.5% | -1.5% | -0.3% | +2.2% | +4.3% | -0.4% | -1.2% | +6.9% | +2.9% | +12.9% | +11.3% | +0.3% | +1.4% | -1.3% | -4.2% | +11.0% | +73.2% | +130.1% | +4.6% | +4.6% | +33.0% | +26.9% | +0.8% | +3.1% | +6.8% | +3.5% | +5.5% | -5.4% | -10.1% | -0.3% | +0.9% | +0.4% | -1.5% | -3.9% | -8.1% | -8.9% | -28.1% | +39.9% | +9.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +755.7% | +87.0% | +1,944.7% | -390.6% | – | – | |
| – | +51.9% | -1.6% | -0.3% | +2.1% | +4.4% | +8.4% | -9.8% | +7.3% | +3.0% | +15.1% | +11.9% | +0.3% | +1.4% | -2.5% | -3.3% | +12.3% | +76.7% | +137.7% | +3.0% | +4.4% | -83.8% | -87.6% | +206.8% | +77.8% | -95.0% | +782.9% | +10.3% | -55.4% | -533.6% | – | -52.9% | +240.7% | +37.2% | -9.7% | +93.0% | -154.9% | – | -53.8% | +7.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +15,790.6% | +153.7% | +1,805.9% | -393.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5,382.2% | – | – | – | – | – | – | – | -1,552.9% | – | – | – | – | – | – | – | – | – | -6.8% | -110.5% | – | +15.5% | +13.1% | +728.6% | -363.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.